Taltz in Combination With Enstilar for Psoriasis
Clinical trial NCT04372277 · RECRUITING
Trial details
- NCT number
- NCT04372277
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-28
- Primary completion
- 2021-03-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.